Vyripharm Enterprises Inc. held its 2022 Legislative Summit For Public Health and Public Safety with Keynote Speaker Congressman Dan Crenshaw

HOUSTON–(BUSINESS WIRE)–Vyripharm Enterprises Inc. and BIZPAC.US hosted the First Annual Vyripharm Public Health and Safety Legislative Reception on August 31, 2022 at the Texas Medical Center (TMC) Institute Innovation Factory, TMC’s 1st phase biotech incubator and accelerator. The purpose of the event was to brief Texas State and Federal legislative members on the importance of … [Read more…]

Caravan Biologix, Inc. Collaborates with MDimune on Cell-Derived NanoVesicles for Cancer

BRISTOL, N.J. & SEOUL–(BUSINESS WIRE)–Caravan Biologix, Inc., a developer of novel cell-derived vesicle (CDV) therapeutics targeting specific cancers and gene therapy-related diseases, today announced that it has entered into an agreement with Seoul-based MDimune Inc. to apply their nanovesicle technology to enhance the effects of chimeric antigen receptor-expressing natural killer (CAR-NK) cells on various solid … [Read more…]

Cintas Corporation Announces the Winners of its 2022 C.A.P.E. Awards

Ten EVS technicians will each receive $2,500 through Cintas’ third-annual EVS award program CINCINNATI–(BUSINESS WIRE)–In honor of Environmental Services (EVS) week, which is being recognized September 11-17, Cintas Corporation (Nasdaq: CTAS) is proud to announce the winners of its 2022 C.A.P.E. Awards. These awards were established to recognize professionals “Cleaning to Advance the Patient Experience.” … [Read more…]

Cardiology Compensation and New Patient Visits Rebound, Survey Finds

10th annual MedAxiom cardiovascular provider compensation and production report reveals year-over-year comparisons and decade trends NEPTUNE BEACH, Fla.–(BUSINESS WIRE)–MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 10th annual Cardiovascular Provider Compensation and Production Survey Report that includes data from the largest number of providers since its debut. The report features a … [Read more…]

Optime Care Recognizes Gene Therapy and Specialty Pharmacy Awareness Month, September 2022

EARTH CITY, Mo.–(BUSINESS WIRE)–Optime Care, a nationally recognized specialty pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, announces its support of the inaugural Gene Therapy and Specialty Pharmacy Awareness month, September 2022. The observance is included in the annual Calendar of Health Observances & Recognition Days, … [Read more…]

Big Health Digital Therapeutics Daylight and Sleepio Selected for Evernorth Digital Health Formulary

The addition of Daylight for anxiety and Sleepio for insomnia expands access to evidence-based digital cognitive behavioral therapy to thousands of Americans SAN FRANCISCO–(BUSINESS WIRE)–Big Health, a digital therapeutics company dedicated to helping millions back to good mental health, today announced that Daylight for anxiety and Sleepio for insomnia have been added to the Evernorth … [Read more…]

Zerigo Health Announces Release of Eczema Solution

Zerigo Health’s latest software release includes integrated, guideline-recommended phototherapy dosing protocols for the treatment of atopic dermatitis (commonly referred to as eczema), in addition to its existing protocols for psoriasis Evernorth, Cigna’s health services business, will offer Zerigo’s solution as part of a pilot program through its Digital Health Formulary and is the first to … [Read more…]

Seoul Semiconductor Applies Violeds Disinfection Technology to Luxury Sedan Genesis G90

Applies violeds technology developed by Seoul Viosys, the world’s number one UV LED company Removes up to 99.9% of harmful germs (E.coli, staphylococcus aureus, and pneumococci) within 10 minutes with UVC Seoul Viosys offers optimized disinfection solutions, operating its own auto lab. ANSAN, South Korea–(BUSINESS WIRE)–#GenesisG90–UV-C disinfection technology solution, Violeds, developed by Seoul Semiconductor Co., … [Read more…]

Aro Biotherapeutics Receives FDA Rare Pediatric Drug Designation for ABX1100 for the Treatment of Pompe Disease

PHILADELPHIA–(BUSINESS WIRE)–Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced that the U.S. Food and Drug Administration (FDA) granted Rare Pediatric Drug (RPD) designation for ABX1100, an investigational Centyrin-siRNA conjugate that targets the Gys1 gene in muscle, for the treatment of Pompe disease. Pompe disease is a rare and deadly … [Read more…]

Attindas Hygiene Partners Announces New Disposable, Invisible Incontinence Underwear Product for Men and Women

The company’s latest product design innovation makes the product fit and feel like regular underwear RALEIGH, N.C.–(BUSINESS WIRE)–#attindas–Attindas Hygiene Partners is proud to announce its innovative new adult disposable incontinence underwear product in North America. Invisible under clothing while providing up to 100% leak-free protection, the new product leverages Maxi Comfort ultrasonic bonding technology for … [Read more…]